SCHEMBL369699

SCHEMBL369699

CCCC(C(=O)Cc1ccc(OC)nc1)c1ccc(Br)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR183 P32249 3/20 0.41
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMO Q99835 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 2/20 0.36
PKM P14618 2/20 0.36
LMNA P02545 1/20 0.36
ACACB O00763 2/20 0.36
OXTR P30559 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
NNMT P40261 1/20 0.35
MET P08581 1/20 0.35
KCNH2 Q12809 1/20 0.35
THRB P10828 1/20 0.34
POLB P06746 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390305 0.93 GPR183 (0.40) GPR183KMT2AALDH1A1KDM4EMEN1
SCHEMBL368252 0.86 GPR183 (0.41) GPR183KMT2AALDH1A1KDM4EMEN1
SCHEMBL1390168 0.86 GPR183 (0.38) GPR183KMT2AALDH1A1MEN1NPC1
SCHEMBL369190 0.85 GPR183 (0.41) GPR183KMT2AALDH1A1KDM4EMEN1
SCHEMBL370462 0.83 SMO (0.36) GPR183KMT2ASMOKDM4EMEN1
SCHEMBL369669 0.76 GPR183 (0.44) GPR183ALDH1A1ACACBSMN1; SMN2KCNH2
SCHEMBL369728 0.76 GPR183 (0.44) GPR183ALDH1A1ACACBSMN1; SMN2KCNH2
SCHEMBL369362 0.76 GPR183 (0.43) GPR183KMT2AALDH1A1MEN1ACACB
SCHEMBL368592 0.75 HDAC4 (0.43) GPR183KMT2AALDH1A1MEN1NPC1
SCHEMBL369863 0.75 SMN1; SMN2 (0.40) GPR183KMT2AALDH1A1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPR183 80/4885KMT2A 3981/4885ALDH1A1 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.